利民控股集团股份有限公司（以下简称"公司"）于 2025年8月14日收到公 司副总裁兼运营中心总监高军从女士提交的书面辞职报告。高军从女士因个人原 因，申请辞去公司副总裁兼运营中心总监职务。根据有关规定，高军从女士的辞 职报告自送达董事会之日起生效，其辞职将不会对公司正常运行造成不利影响。 辞去上述职务后，高军从女士不再担任公司及子公司任何职务。 截至本公告日，高军从女士未持有公司股份，不存在应当履行而未履行的承 诺事项。 高军从女士在担任公司副总裁兼运营中心总监期间勤勉尽责、恪尽职守，为 公司规范运作和发展成长发挥了重要作用，公司及董事会对高军从女士任职期间 为公司所做出的贡献表示衷心感谢。 股票代码：002734 股票简称：利民股份 公告编号：2025-069 利民控股集团股份有限公司 关于副总裁辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特此公告。 利民控股集团股份有限公司董事会 ...

股票代码：002734 股票简称：利民股份 公告编号：2025-070 债券代码：128144 债券简称：利民转债 利民控股集团股份有限公司 第六届董事会第九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 利民控股集团股份有限公司董事会 -1- 利民控股集团股份有限公司（以下简称"公司"）第六届董事会第九次会议于 开。应出席本次会议的董事 11 名，实际出席会议的董事 11 名。会议由董事长李新 生先生主持。公司全体监事及高级管理人员列席了会议。本次会议的出席人数、召 开表决程序、议事内容均符合《公司法》《公司章程》等有关规定。 会议以赞成票 11 票，反对票 0 票，弃权票 0 票，审议通过了《关于 <公司 ensp="ensp"> 年半年度报告及其摘要>的议案》。 《公司 2025 年半年度报告全文》及《公司 2025 年半年度报告摘要》刊登于巨 潮资讯网，并批准 2025 年半年度财务报告对外报出。《公司 2025 年半年度报告摘 要》还刊登于 2025 年 8 月 15 日出版的《证券时报》和《中国证券报》。 备查文件： 特此公告。 ...

Core Viewpoint - Limin Holdings Group Co., Ltd. reported significant growth in its financial performance for the first half of 2025, with notable increases in revenue and net profit compared to the same period last year [2][3]. Financial Performance - The company's operating revenue for the reporting period reached approximately CNY 2.45 billion, representing a year-on-year increase of 6.69% from CNY 2.30 billion [2]. - The net profit attributable to shareholders surged to approximately CNY 268.85 million, marking a substantial increase of 747.13% compared to CNY 31.74 million in the previous year [2]. - The net profit after deducting non-recurring gains and losses was not specified in the provided data [2]. - The basic earnings per share rose to CNY 0.69, reflecting a 666.67% increase from CNY 0.09 [2]. - The diluted earnings per share also increased to CNY 0.60, up 566.67% from CNY 0.09 [2]. - The weighted average return on equity improved to 7.56%, compared to 6.39% in the previous year [2]. Cash Flow and Assets - The net cash flow from operating activities was negative at approximately CNY -114.18 million, which is a 180.08% decrease from CNY 91.44 million in the previous year [2]. - Total assets at the end of the reporting period were approximately CNY 6.78 billion, a 1.77% increase from CNY 6.66 billion at the end of the previous year [3]. - The net assets attributable to shareholders increased by 31.58% to approximately CNY 3.48 billion from CNY 2.64 billion [3]. Shareholder Information - The top shareholders include Li Ming and Li Xinsong, who hold 16.72% and 10.14% of the shares, respectively, with both having pledged their shares [3][4]. - The company did not experience any changes in its controlling shareholders or actual controllers during the reporting period [4]. Debt and Financial Ratios - The company's debt-to-asset ratio was reported at 47.78%, a decrease from 59.53% in the previous year [4]. - The EBITDA interest coverage ratio improved significantly to 16.29 from 6.89 in the previous year [4].

Key Points - Tianpu Co., Ltd. is planning a change in control, leading to a suspension of trading from August 15, 2025, for up to two trading days [2] - Chipsea Technology and Shunhao Co., Ltd. are preparing to issue H-shares and list on the Hong Kong Stock Exchange, with plans to consider shareholder interests and market conditions [3] - ST Suwu's stock closed at 0.99 yuan on August 14, 2025, which is below the 1 yuan threshold that could lead to delisting after 20 consecutive trading days [4] Financial Performance - Bubu Gao reported a revenue of 2.129 billion yuan for the first half of 2025, a year-on-year increase of 24.45%, with a net profit of 201 million yuan [6] - Kelun Electronics achieved a revenue of 2.573 billion yuan, up 34.66% year-on-year, with a net profit of 190 million yuan [6] - Limin Co., Ltd. reported a revenue of 2.452 billion yuan, a 6.69% increase, and a net profit of 269 million yuan, up 747.13% [6] - Zhongguang Fanglong reported a revenue of 217 million yuan, a 10.31% increase, and a net profit of 10.6787 million yuan, up 321.87% [6] - Chuanjin Nuo reported a revenue of 1.744 billion yuan, a 27.91% increase, and a net profit of 177 million yuan, up 166.51% [6] - Taicheng Light reported a revenue of 828 million yuan, a 62.49% increase, and a net profit of 173 million yuan, up 118.02% [7] - Huagong Technology reported a revenue of 7.629 billion yuan, a 44.66% increase, and a net profit of 911 million yuan, up 44.87% [8] - Yifan Pharmaceutical reported a revenue of 2.635 billion yuan, a slight increase of 0.11%, and a net profit of 304 million yuan, up 19.91% [8] - Xidian New Energy reported a revenue of approximately 1.39 billion yuan, a 65.90% increase, and a net profit of approximately 139 million yuan, up 51.66% [8] - China Telecom reported a revenue of 269.4 billion yuan, a 1.3% increase, and a net profit of 23 billion yuan, up 5.5% [9] Important Transactions - Kangda New Materials plans to acquire 51% of Chengdu Zhongke Huamei Electronics for 275.4 million yuan, aiming to expand in the semiconductor integrated circuit field [13] - Jingu Co., Ltd. signed a strategic cooperation agreement with Luming Robotics to explore new material applications in robotics [13] - Zhaowei Electromechanical plans to invest up to 100 million USD in a new production base in Thailand [13] - Zhongyuan Neipei's subsidiary received a notification to supply smart electric control actuators for a European engineering group, with a projected sales amount of approximately 490 million yuan over nine years [14] - Jiadian Co., Ltd. won a bid for nuclear power project equipment worth approximately 608.98 million yuan [14] - Shenzhen Airport reported a passenger throughput of 5.4352 million in July 2025, a 2.02% year-on-year increase [14] - Gansu Energy Chemical received approval to resume production at a coal mine after safety inspections [14]

Core Insights - The company reported a revenue of 2.45 billion yuan for the first half of 2025, representing a year-on-year growth of 6.69%, and a net profit attributable to shareholders of 269 million yuan, showing a significant increase of 747.13% [1] - The company's profitability has improved, with a notable decrease in the asset-liability ratio, and the management of production bases has been upgraded, leading to substantial enhancements in overall efficiency [1] Group 1 - The company is a leading domestic pesticide manufacturer with five differentiated production bases located in Jiangsu, Hebei, and Inner Mongolia, with an annual capacity of 110,200 tons for active ingredients and 132,700 tons for formulations [1] - The product line covers a full range of pesticides, including key varieties such as Mancozeb, Abamectin, Methomyl, and Glyphosate [1] Group 2 - The company is proactively developing biocontrol technologies through independent or collaborative development of cutting-edge products like RNAi biopesticides and small peptide biopesticides [2] - The company has established the Deyanzhichuang platform, utilizing AI tools to enhance compound development efficiency and shorten the screening cycle for new compounds [2] Group 3 - The company has accelerated its international expansion, with an overseas operation center in Singapore connecting strategic markets in Africa, Southeast Asia, and Latin America [2] - The company has been deeply engaged in the Tanzanian market for 20 years and successfully expanded into Kenya in 2024, while also preparing to establish a subsidiary in Southeast Asia and advancing operations in Brazil and Mexico [2] Group 4 - The company possesses a rich pesticide registration resource library with 316 pesticide registration certificates, including 50 for active ingredients and 266 for formulations, maintaining an annual addition of approximately 20 new registrations [3] - The abundant product registrations enable the company to quickly allocate resources and focus on high-value, differentiated products to meet customer demands [3]

Group 1 - The company reported a total operating revenue of 2,452,036,963.81 yuan for the first half of 2025, representing a year-on-year growth of 6.69% [2] - The net profit attributable to shareholders of the listed company reached 268,846,594.55 yuan, showing a significant year-on-year increase of 747.13% [2]

Core Viewpoint - The company reported significant growth in both revenue and net profit for the first half of 2025, indicating strong financial performance and operational efficiency [1] Financial Performance - The company achieved operating revenue of 2.452 billion yuan, representing a year-on-year increase of 6.69% [1] - The net profit attributable to shareholders reached 269 million yuan, showing a remarkable year-on-year growth of 747.13% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 257 million yuan, reflecting an impressive year-on-year increase of 804.41% [1] - Basic earnings per share were reported at 0.69 yuan [1]

Group 1 - The company announced the resignation of its Vice President and Operations Center Director, Gao Jun, due to personal reasons [2] - The resignation was officially submitted on August 14, 2025 [2] - This change in leadership may impact the company's operational strategies moving forward [2]

报告期内，公司盈利能力得到提升，资产负债率明显下降。化学合成创制计划稳步推进，与跨国公司的 创新药开发合作进展顺利，产品规划梯次形成，配方研究水平不断提高，生物合成的研究方向扎实开 展。 人民财讯8月14日电，利民股份（002734）8月14日晚间披露2025年半年报，公司上半年实现营收24.52 亿元，同比增长6.69%；实现归属于上市公司股东的净利润2.69亿元，同比增长747.13%。 ...

（文章来源：每日经济新闻） 利民股份（SZ 002734，收盘价：21.65元）8月14日晚间发布半年度业绩报告称，2025年上半年营业收 入约24.52亿元，同比增加6.69%；归属于上市公司股东的净利润约2.69亿元，同比增加747.13%；基本 每股收益0.69元，同比增加666.67%。 ...